Impact of Routines and Rituals on Burden of Treatment, Patient Training, Cognitive Load, and Anxiety in Self-Injected Biologic Therapy-Reference-Cited by-同舟云学术

Impact of Routines and Rituals on Burden of Treatment, Patient Training, Cognitive Load, and Anxiety in Self-Injected Biologic Therapy

Published:2022-09 Issue: Volume:Volume 16 Page:2593-2607
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Coyne Marty,Rinaldi Amy^ORCID,Brigham Katherine,Hawthorne James^ORCID,Katsaros Dimos,Perich Morgan,Carrara Nicholas,Pericaud Flore,Franzese Chris,Jones Graham^ORCID

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference55 articles.

1. Biologic therapies in inflammatory bowel disease

2. Advancements in the Treatment of Psoriasis: Role of Biologic Agents

3. Biologic Therapy for Psoriatic Arthritis

4. New biological agents in the treatment of multiple sclerosis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of self‐administration experience with a new injection device: Real‐life experience with risankizumab in patients with psoriasis;Skin Research and Technology;2024-08

2. Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product design;Advanced Drug Delivery Reviews;2024-06

3. Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design;Advanced Drug Delivery Reviews;2024-06

4. International Survey to Evaluate Current Options for Subcutaneous Injection of Methotrexate (MTX) and a New Button-Free MTX Autoinjector;Patient Preference and Adherence;2024-03

5. Preferences and Perspectives of Specialist Multiple Sclerosis Nurses and Patients with Multiple Sclerosis Regarding the New RebiSmart® 3.0 Autoinjector versus Other Assistive Devices;Medical Devices: Evidence and Research;2024-02